Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Novel titanate-catalyzed route for high-purity deuterated standards. Enhances supply chain stability and reduces forensic analysis costs significantly for global labs.
Patent CN101817835B reveals a novel pentafluorophenol activation route for Cefdinir, offering high purity, relaxed anhydrous conditions, and significant cost reduction in antibiotic manufacturing.
Patent CN101565427B details a green synthesis route for Cefdinir using low-temperature hydrolysis and recoverable solvents, offering significant cost reduction in pharmaceutical manufacturing.
Patent CN102617601A details a cost-effective cefdinir method using mesyl chloride activation, ensuring high purity and scalable production for global pharmaceutical supply chains.
Patent CN117164645A reveals metal-free DDQ oxidation for thioglycosides. Enhances purity and scalability for reliable pharmaceutical intermediates supplier partnerships.
Novel glycosylation route for immune boosting glucan pentasaccharide. Enhances supply chain reliability and reduces manufacturing complexity for pharmaceutical intermediates.
Patent CN106674040B details catalyst-free N-aryl amide synthesis offering significant cost reduction and supply chain reliability for high-purity pharmaceutical intermediates manufacturing.
Novel AgF-catalyzed route for 1-trifluoromethyl indoles offers cost-effective, scalable production for pharma and agrochemical supply chains.
Novel one-step synthesis route ensures high purity impurity standards for regulatory compliance and supply chain stability in pharmaceutical manufacturing.
Patent CN111995569B details a novel CuI catalyzed route reducing costs and improving purity for scalable pharmaceutical intermediates manufacturing supply chains.
Patent CN111471003A details a novel Negishi coupling route for sitagliptin intermediates, offering high purity and reduced steps for reliable pharmaceutical intermediate supply chains.
Patent CN117105887A reveals a novel Salen Co-catalyzed resolution for chiral epichlorohydrin. Achieve high purity, catalyst recycling, and significant cost reduction in pharmaceutical manufacturing.
Patent CN114907300B details a cost-effective route for Tazemetostat intermediates, offering enhanced purity and scalable manufacturing for global supply chains.
Novel patent CN116120387B enables safer dydrogesterone production. Eliminating ozone risks ensures high purity supply chain reliability for global pharmaceutical manufacturers seeking intermediates.
Patent CN114891049B introduces stable o-alkynyl benzyl ether donors for high-efficiency glycoside synthesis, offering cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN113121619B discloses mild glycosylation using Kass reagent. Achieve high yield, stereoselective phenolic glycosides for reliable pharmaceutical intermediate supply.
Novel enzymatic route for 2-deoxy-2,2-difluoro-3,5-dibenzoyl-D-ribofuranose offers high yield and purity, replacing hazardous hydrogenation for reliable supply.
Advanced asymmetric total-synthesis method for chiral Huperzine A using Cinchona alkaloids. Delivers high optical purity and scalable manufacturing for Alzheimer's therapeutics.
Patent CN103288630A details a novel synthesis of Sodium Danshensu from L-Tyrosine. This report analyzes the DKR strategy for cost-effective, high-purity API intermediate manufacturing.
Patent CN108586486A reveals a novel synthesis route for thienopyrimidine intermediates offering enhanced yield and supply chain stability for pharmaceutical manufacturing partners.